LTR Pharma has entered into an exclusive pilot commercialisation agreement with Marius Pharmaceuticals, a US pharmaceutical company focused on men’s health, to introduce Marius’ lead

LTR Pharma has executed a definitive Compounding and Supply Agreement with Strive Specialties Inc., a leading U.S. Section 503A compounding pharmacy, converting the previously announced

LTR Pharma has executed a definitive Telehealth Distribution Agreement with Shed Holdings LLC, a leading U.S. direct-to-consumer telehealth platform, converting the previously announced binding Term

LTR Pharma has signed a term sheet with Strive Specialties, a United States personalised medicine and 503A pharmacy for ROXUS®.   This establishes the pharmacy fulfilment infrastructure required to supply

News update: Leading Australian medical experts are driving public awareness and conversation about the increased severity and prevalence of sexual issues in men aged 65+,

Edison has released a report on LTR Pharma, highlighting the clinical validation of SPONTAN as a fast-acting intranasal treatment for erectile dysfunction and its progression